product image
Schizophrenia vs Bipolar disorder: Biomarkers to the rescue

Jun 30, 2020

Schizophrenia and Bipolar disorder (BD) are most of the times difficult to distinguish. Schizophrenia is characterized by hallucinations, and delusions when a patient loses...

Read More
product image
Novel treatment approval promises a better future for Sickle cell disease patients

Nov 27, 2019

Sickle cell disease is a haematological, genetic disorder that affects millions of people worldwide. According to the NIH, “Sickle cell disease is the most common inherit...

Read More
product image
Antimicrobial resistance crisis: A global need for antibiotic awareness

Jun 26, 2020

Antimicrobial resistance (AMR) is a global threat. As per the UN estimates, the global trends reveal that each year 7,00,000 people die due to drug-resistance. Moreover, ar...

Read More
product image
Beta-Thalassemia Pharmacological Therapies

Feb 5, 2020

Thalassemia is a group of inherited blood disorders that are a result of defects or mutations in the genes. The defect results in defective or less production of the haemog...

Read More
product image
Geographic Atrophy Treatment Market: Novel Therapies to Enter the Market

Jul 20, 2020

Geographic atrophy (GA) is a severe, progressive, irreversible vision loss in old age people. The loss in the vision is due to the damage in a small portion of the retina a...

Read More
product image
Biogen seeks the FDA approval to revive its Alzheimer’s drug Aducanumab

Jun 26, 2020

Not a long time ago this year, Biogen announced the halting of Phase III clinical trials, EMERGE and ENAGE, of its most looked upon drug aducanumab under simulations for th...

Read More
product image
Hyperthyroidism Treatment Market and Drugs

Sep 25, 2019

Hypoparathyroidism is a rare endocrine condition marked by low-calcium and high-phosphate levels as compared to a normally lower or inappropriate level of normal Parathyroi...

Read More
product image
FDA approves Ibsrela to reduce the global burden of Irritable Bowel Syndrome

Jul 3, 2020

Recently the U.S. Food and Drug Administration has recommended the use of Ibsrela (tenapanor), for the treatment of irritable bowel syndrome with constipation (IBS-C) in ad...

Read More
product image
Driving factors boosting the Hepatocellular Carcinoma Market

Jun 30, 2020

The present Hepatocellular Carcinoma market size is mainly dominated by the protein Kinase inhibitor i.e., Nexavar (Sorafenib) developed by Bayer is considered the first li...

Read More
product image
What lies in the future for NASH upcoming drugs?

Feb 14, 2020

NAFLD is one of the leading causes of liver damage in the younger population. The increasing NAFLD prevalence runs parallel with the increasing trends in obesity among peop...

Read More
product image
FDA approves Non-Controlled treatment for Excessive Daytime Sleepiness

Jul 3, 2020

The U.S. Food and Drug Administration has approved WAKIX (pitolisant) to treat excessive daytime sleepiness (EDS) in adult patients with narcolepsy. The Narcolepsy therapy,...

Read More
product image
Psoriasis Pipeline: Upcoming Psoriasis Treatments

Jul 2, 2020

Psoriasis is a debilitating inflammation of skin affecting approximately 7.4 million adults in the United States. Recent researches demonstrating a surge in the Psoriasis p...

Read More
product image
HIV Treatment Landscape and A New Approach

Feb 14, 2020

The Human immunodeficiency virus (HIV) cases have grown to pandemic extents since the first case of acquired immunodeficiency syndrome (AIDS) was reported in 1981. CDC esti...

Read More
product image
Frightening Surge in HIV-drug Resistance: The Biggest Challenge Ahead

Feb 14, 2020

In a survey conducted by WHO, globally, 37.9 million people were tested positively living with HIV in 2018. Out of which, 62% (23.3 million) of the people were receiving an...

Read More
product image
Is it Okay to take Antibiotics without a prescription?

Feb 5, 2020

Antibiotics are amazing. Right? There was a time when thousands of people lost their lives due to some severe bacterial diseases. However, thanks to the British scientist A...

Read More